Exact Mass: 377.0567152

Exact Mass Matches: 377.0567152

Found 97 metabolites which its exact mass value is equals to given mass value 377.0567152, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glucosisymbrin

1-Methyl-2-hydroxyetyl glucosinolate

C10H19NO10S2 (377.0450354)

KG-501

N-(4-Chlorophenyl)-3-(phosphonooxy)naphthalene-2-carboxamide

C17H13ClNO5P (377.02198480000004)

2-Hydroxypropyl glucosinolate

{[(e)-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}butylidene)amino]oxy}sulphonic acid

C10H19NO10S2 (377.0450354)

2-Hydroxypropyl glucosinolate is found in brassicas. 2-Hydroxypropyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 2-Hydroxypropyl glucosinolate is found in horseradish and brassicas.

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3OS (377.0998058)

N-Hbgd

6-({[4-(hydroxymethyl)phenyl]methyl}[sulphanyl(carbonothioyl)]amino)hexane-1,2,3,4,5-pentol

C15H23NO6S2 (377.0966738)

S-Pyruvylglutathione

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-oxopropanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C13H19N3O8S (377.0892814)

3-Hydroxypropyl glucosinolate

C10H19NO10S2 (377.0450354)

RIT-D-2214

C13H19N3O6S2 (377.0715234)

7-Methyl-XMP

7-Methylguanosine 5-monophosphate

C11H16N5O8P (377.0736466)

7-chloro-(2R)-2-O-beta-D-glucopyranosyl-4-hydroxy-2H-1,4-benzoxazin-3(4H)-one|7-Cl-DIBOA-Glc

C14H16ClNO9 (377.05135559999997)

SB 203580

4-[4-(4-fluorophenyl)-2-[4-methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine

C21H16FN3OS (377.0998058)

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

12-Hydroxychelirubine

C21H15NO6 (377.08993300000003)

3-Hydroxypropyl-Glucosinolate

C10H19NO10S2 (377.0450354)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

FR167356

Benzamide, 2,6-dichloro-N-(3-(1-hydroxy-1-methylethyl)-2-methyl-7-benzofuranyl)-

C19H17Cl2NO3 (377.05854320000003)

CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8799; ORIGINAL_PRECURSOR_SCAN_NO 8796 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8818; ORIGINAL_PRECURSOR_SCAN_NO 8815 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8849; ORIGINAL_PRECURSOR_SCAN_NO 8845 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8855; ORIGINAL_PRECURSOR_SCAN_NO 8850 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8828; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 245; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8869; ORIGINAL_PRECURSOR_SCAN_NO 8867

S-Pyruvylglutathione

C13H19N3O8S (377.0892814)

Asn-His-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H15N5O7 (377.097144)

2-Hydroxypropyl glucosinolate

{[(E)-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxy}sulfonic acid

C10H19NO10S2 (377.0450354)

4-(2-Chlorophenyl)-5-methoxycabonyl-3-ethoxycarbonyl-6-methylpicolinic acid

C18H16ClNO6 (377.06661060000005)

Omeprazole Sulfone N-Oxide

C17H19N3O5S (377.10453640000003)

Fenthiaprop

C18H16ClNO4S (377.0488526000001)

(4aR,8aR)-1-Bromo-3-methoxy-6-oxo-5,6,9,10-tetrahydro-4aH-[1]benz ofuro[3a,3,2-ef][2]benzazepine-11(12H)-carbaldehyde

C17H16BrNO4 (377.02626360000005)

N-BOC-2-BROMO-5-BENZYLOXYANILINE

C18H20BrNO3 (377.0626470000001)

7-(4-BROMO-2,6-DIMETHYLPHENYL)-4-CHLORO-2,5,6-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE

C17H17BrClN3 (377.02942920000004)

5-nitrofluorescein

C20H11NO7 (377.0535496)

Scopine Di(2-thienyl) Glycolate

C18H19NO4S2 (377.0755454)

Benzenesulfonic acid,4-hydroxy-5-(2-hydroxy-4-methoxybenzoyl)-2-methoxy-, sodium salt (1:1)

C15H14NaO8S+ (377.03070640000004)

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

C22H16FNO4 (377.1063308)

UNII:S1199Y391N

C14H15N7O2S2 (377.072861)

2-BROMO-6-IODO-3-METHOXYPYRIDINE

C22H16FNO4 (377.1063308)

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.0990304)

ethyl 2-[4-[(6-chlorobenzothiazol-2-yl)oxy]phenoxy]propionate

C18H16ClNO4S (377.0488526000001)

2H-Pyrrol-2-one, 4-acetyl-1-(4-bromophenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

C18H20BrNO3 (377.0626470000001)

Ronifibrate

3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl pyridine-3-carboxylate

C19H20ClNO5 (377.1029940000001)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates

4,4,4-Nitrilotribenzoic acid

C21H15NO6 (377.08993300000003)

ERRα antagonist-1

C21H19N3S2 (377.10203340000004)

1-PIPERIDINECARBOXYLIC ACID 4-(4-IODO-1H-PYRAZOL-1YL)-,1-1-DIMETHYLETHYLESTER

C13H20IN3O2 (377.060021)

Robenidine-d8 HCl

C15H6Cl3D8N5 (377.081690824)

Methyl 2-BroMo-3-(4-(2-(3-Methylpyridin-2-yl)ethoxy)phenyl)propanoate

C18H20BrNO3 (377.0626470000001)

5-Bromodescyano Citalopram

C19H21BrFNO (377.0790448)

4-Nitrofluorescein

C20H11NO7 (377.0535496)

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

C21H16FN3OS (377.0998058)

Glufanide disodium

C16H17N3Na2O5 (377.0963552)

D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D020011 - Protective Agents > D000931 - Antidotes C308 - Immunotherapeutic Agent D007155 - Immunologic Factors

Acridine half-mustard

C19H21Cl2N3O (377.1061596)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D009153 - Mutagens

COX-2 Inhibitor I

C18H16ClNO4S (377.0488526000001)

2-(4-morpholinyl)-N-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide

C15H15N5O5S (377.07938600000006)

2-O-Methylguanosine 5-monophosphate

C11H16N5O8P (377.0736466)

1-(4-Bromo-2,5-dimethoxyphenyl)sulfonylazepane

C14H20BrNO4S (377.0296340000001)

1-Methylguanosine 5-(dihydrogen phosphate)

C11H16N5O8P (377.0736466)

Ethyl 2-amino-4-(4-chlorophenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carboxylate

C18H16ClNO6 (377.06661060000005)

N-[3-chloro-4-(4-morpholinyl)phenyl]-1,1-dioxo-1,2-benzothiazol-3-amine

C17H16ClN3O3S (377.0600856)

N-(1,3-benzodioxol-5-yl)-3-methyl-6-phenyl-2-imidazo[2,1-b]thiazolecarboxamide

C20H15N3O3S (377.0834080000001)

2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid

C17H10F3N3O2S (377.0445796)

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

C21H13F2N3O2 (377.09757820000004)

7,8-Dihydro-8-oxo-guanosine 5-phosphate

C10H12N5O9P-2 (377.03726320000004)

N2-hydroxyguanosine 5-monophosphate

C10H12N5O9P-2 (377.03726320000004)

4,5-Dihydrofarnesyl diphosphate

C15H23O7P2-3 (377.0918968)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-4-hydroxy-N-sulfooxybutanimidothioate

C10H19NO10S2 (377.0450354)

S-lactoylgluta-thione

C13H19N3O8S (377.0892814)

4-[(3,5-Dichloro-2-hydroxyphenyl)methylamino]-1,5-dimethyl-2-phenyl-3-pyrazolone

C18H17Cl2N3O2 (377.06977620000004)

N-[[4-(dimethylsulfamoyl)anilino]-sulfanylidenemethyl]-2-phenylacetamide

C17H19N3O3S2 (377.0867784)

1-[[(E)-(3-bromo-6-keto-cyclohexa-2,4-dien-1-ylidene)methyl]amino]-3-phenethyl-thiourea

C16H16BrN3OS (377.01973860000004)

N(7)-methylguanosine 5-phosphate

C11H16N5O8P (377.0736466)

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

C19H21Cl2N3O (377.1061596)

4-bromo-N-(2-phenazinyl)benzamide

C19H12BrN3O (377.0163682)

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

C18H19NO6S (377.0933034)

N(2)-methylguanosine 5-monophosphate

C11H16N5O8P (377.0736466)

8-chloro-N-(4-fluorophenyl)-2-(2-pyridinyl)-4-quinolinecarboxamide

C21H13ClFN3O (377.07311300000003)

N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamide

C17H16BrNO4 (377.02626360000005)

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

C20H15N3O5 (377.10116600000003)

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

C15H18F3N3O3S (377.10209140000006)

N-[(E)-[4-(2,3-Dichloroanilino)-4-oxobutan-2-ylidene]amino]-2-methylbenzamide

C18H17Cl2N3O2 (377.06977620000004)

1-[4-[4-[(5-Bromo-2-furanyl)methylamino]phenyl]-1-piperazinyl]ethanone

C17H20BrN3O2 (377.07388000000003)

(5E)-5-[[1-(4-chloro-2-fluorophenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

C18H17ClFN3OS (377.07648340000003)

2-[(3,4,8,9,10-Pentahydroxy-6-oxobenzo[c]chromene-1-carbonyl)amino]acetic acid

C16H11NO10 (377.0382946)

Adaptaquin

C21H16ClN3O2 (377.0930986)

Adaptaquin is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PHD2), with an IC50 of 2 μM. Adaptaquin can inhibit lipid peroxidation and maintain mitochondrial function[1][2].

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[(2s)-1-hydroxy-3-[(r)-(r)-methanesulfinylmethanesulfinyl]propan-2-yl]prop-2-enimidic acid

C13H19N3O6S2 (377.0715234)

7-cl-diboa-glc

C14H16ClNO9 (377.05135559999997)

{"Ingredient_id": "HBIN013138","Ingredient_name": "7-cl-diboa-glc","Alias": "NA","Ingredient_formula": "C14H16ClNO9","Ingredient_Smile": "C1=CC2=C(C=C1Cl)OC(C(=O)N2O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3815","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}